Recruiting
Nutrition for Asthmatics
Determine to what extent three distinct dietary approaches improve asthma control and lung function.
ClinicalTrials.gov IDNCT06151405
PhaseNA
Enrollment15
SponsorPennington Biomedical Research Center
Age18 Years – 65 Years
SexALL
Conditions studied
Asthma
About this study
Determine to what extent three distinct dietary approaches improve asthma control and lung function.
Interventions
- Other: DGA Diet — A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans (DGA) Including: * A variety of vegetables and fruits * Grains, at least half of which are whole grains * Fat-free or low-fat dairy * A variety of protein foods, including seafood, lean meats and poultry, eggs, legumes, nuts, and seeds * This healthy eating pattern also limits saturated fats and trans fats, added sugars, and sodium.
- Other: MCT Diet — A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).
- Other: KETO Diet — A fully provisioned isocaloric, isonitrogenous ketogenic study diet.
Primary outcomes
- Asthma Control (Baseline)
- Asthma Control (After 7 days on Diet#1)
- Asthma Control (After 7 days on Diet#2)
- Asthma Control (After 7 days on Diet#3)
- Lung Function (Baseline)
- Lung Function (After 7 days on Diet#1)
- Lung Function (After 7 days on Diet#2)
- Lung Function (After 7 days on Diet#3)
Eligibility information
Inclusion Criteria:
* Age: 18-65 years
* BMI: 18.5 - 29.99 kg/m2
* asthma diagnosed by medical specialist (confirmed in medical history)
* partly controlled or uncontrolled asthma by Asthma Control Test score ≤22
* owns a device compatible with ZEPHYRx platform
* stable asthma medication use (no change in the past 2 months).
Exclusion Criteria:
* Diabetes or using diabetes medications that may lower blood glucose levels
* point of care fasting blood glucose ≥126 mg/dl or triglycerides ≥400 mg/dl
* current smoking or smoking history of greater than 10 pack-years
* other significant respiratory or cardiac disease or the presence of clinically important comorbidities, e.g., COPD, renal failure, liver disease; uncontrolled hypertension defined as systolic blood pressure ≥160 mm/Hg, or diastolic blood pressure ≥100 mm/Hg
* pregnant or nursing women
* food preferences or allergies inconsistent with study diet capabilities
* noncompliance with lead-in period requirements.
Study locations
- Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-10.